Loading clinical trials...
Loading clinical trials...
Undersökning av ny Behandlingsmetod Vid migränanfall (Evaluation of a New Treatment for Migraine Attacks)
The purpose of this study is to evaluate the efficacy of a novel therapy for treatment of migraine, pain reduction and relief of associated symptoms during ongoing migraine attacks, and presence of a preventive effect two months post treatment. Another purpose is to investigate if and how this treatment affects manifestations of the autonomic nervous system activity.
Age
20 - 55 years
Sex
ALL
Healthy Volunteers
No
Karolinska University Hospital, Huddinge
Stockholm, Sweden
Start Date
January 1, 2012
Last Updated
June 18, 2013
40
ESTIMATED participants
In-house prototype invented by Jan-Erik Juto
DEVICE
In-house prototype invented by Jan-Erik Juto
DEVICE
Lead Sponsor
Karolinska University Hospital
NCT06641466
NCT07018713
NCT04715685
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions